Dog Joint Supplements: Evidence Review

A critical look at the scientific evidence behind popular joint supplements for dogs, including glucosamine, chondroitin, and omega-3 fatty acids.

Key Facts

Canine osteoarthritis affects an estimated 20% of dogs over one year old
Glucosamine and chondroitin are among the most widely sold dog supplements globally
A 2007 Cochrane-style review found limited high-quality evidence for glucosamine in dogs
Omega-3 fatty acids (EPA and DHA) have more robust evidence for reducing joint inflammation
Green-lipped mussel extract showed modest benefits in small controlled trials
Uncontrolled studies show much larger benefits than blinded randomized trials
Placebo effects in owners assessing their pets can significantly inflate perceived benefit
The veterinary supplement industry is less regulated than pharmaceuticals in most countries

Welfare Considerations

Dogs with arthritis experience genuine pain and reduced mobility, making effective treatment a serious welfare concern. The challenge is that many popular supplements lack robust evidence, yet owners spend significantly on them, potentially delaying access to better-evidenced interventions. Omega-3 supplementation and weight management have stronger evidence bases. Working with a veterinarian to implement a multi-modal pain management plan — including NSAIDs when appropriate, physiotherapy, and environmental modifications — provides better welfare outcomes than relying on unproven supplements alone.

What You Can Do

Consult a veterinarian before starting any supplement regimen for a dog with joint problems
Ask specifically about omega-3 fatty acids, which have stronger evidence than glucosamine
Consider veterinary physiotherapy or hydrotherapy alongside any supplement use
Maintain healthy body weight — the single most impactful intervention for arthritic dogs
Support research into veterinary joint health by participating in clinical trials if eligible
Advocate for stronger regulation of veterinary supplement claims